Company

ImmPACT Bio

Biotechnology Research Il 64 employees

Employees: 64
Contacts: 3
Emails: 3
Phones: 1

immpactbio.com LinkedIn

ImmPACT Bio Overview

Headquarters: Il
Website: immpactbio.com
Industry: Biotechnology Research
Employees: 64
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

CAR-T Immunotherapy Cancer Therapy On target off tumor toxicity Selective treatment Logic gate Oncology Biotechnology Research Immunotherapy autoimmune lupus

About ImmPACT Bio

ImmPACT Bio is now part of Lyell Immunopharma. Learn how we are continuing to advance next-generation cell therapies that offer patients improved outcomes @Lyell or www.lyell.com. About ImmPACT Bio: ImmPACT Bio USA, Inc., is a clinical-stage company dedicated to the discovery of transformative chimeric antigen receptor (CAR) T-cell therapies that address key biological challenges in treating cancer and autoimmune diseases. Our technology is designed to precisely distinguish cancer and diseased cells from normal cells; thereby eliminating them without damaging normal tissues. The company was founded in 2017 in the FuturRx incubator (Israel). In 2019, ImmPACT Bio was incorporated in the US. In 2021 ImmPACT Bio merged with Kalthera. In 2022 we moved our Corporate offices to West Hills, CA and built a state-of-the-art clinical manufacturing facility.

ImmPACT Bio Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 1; 25.0% coverage

ImmPACT Bio Org Chart

Sample employees and titles

Name	Title	Location	Contact
Suzzane Chung	QA Senior Manager, Quality Systems	Los Angeles County, California, United States	Email
Han Lee	President and CFO	San Diego Metropolitan Area, United States	Email Phone
Jolie Keough	Vice President, Human Resources		View
Chance Anderson	Sr. Supplier Quality Manager at Lyell Immunopharma	Simi Valley, California, United States	Email